CAS: 1798328-24-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TD52 REF: IN-DA01EQFNCAS: 1798328-24-1 | 99% | To inquire | Thu 09 Jan 25 |
 | TD52 REF: TM-T35528CAS: 1798328-24-1 | 99.5% | 67.00 €~94.00 € | Thu 16 Jan 25 |
 | N2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine REF: 3D-YWC32824CAS: 1798328-24-1 | Min. 95% | To inquire | Thu 20 Feb 25 |
Ref: IN-DA01EQFN
| 50mg | 463.00 € | ||
| 100mg | 556.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Thursday 9 Jan 2025
TD52
CAS:1798328-24-1
TD52, an Erlotinib derivative, is an oral CIP2A cancer inhibitor that disrupts Elk1's attachment to …
Formula:
C24H16N4
Purity:
99.5%
Color and Shape:
Liquid
Molecular weight:
360.41
Ref: TM-T35528
| 2mg | 94.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
N2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine
CAS:1798328-24-1
N2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine is a small molecule that inhibits the activity of protein kinase C and calcium …
Formula:
C24H16N4
Purity:
Min. 95%
Molecular weight:
360.41 g/mol
Ref: 3D-YWC32824
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 20 Feb 2025
